← 返回

鼻型结外 NK/T 细胞淋巴瘤患者生存预测的影像组学-临床列线图的开发

英文原题:Development of a Radiomic-clinical Nomogram for Prediction of Survival in Patients with Nasal Extranodal Natural Killer/T-cell Lymphoma.

查看英文原题

Development of a Radiomic-clinical Nomogram for Prediction of Survival in Patients with Nasal Extranodal Natural Killer/T-cell Lymphoma.

PubMed 2025/01/01(内容时间) Curr Med Imaging Q4 · IF 1.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

Rad-score 与鼻 ENKTL 患者的 OS 显著相关。此外,基于 MRI 的影像组学列线图可用于风险分层,并可能指导个体化治疗决策。

研究思路结论见上方概要

鼻型结外NK/T细胞淋巴瘤(ENKTL)准确可靠的预后模型对于生存结局和个体化治疗至关重要。目前,鼻型ENKTL患者预后模型中尚无基于磁共振成像(MRI)的影像组学分析。

我们旨在探讨基于MRI的影像组学特征在鼻型ENKTL患者预后中的价值。

共纳入159例鼻ENKTL患者,随机分为训练队列(n=81)和验证队列(n=78)。分别提取治疗前MRI检查的影像组学特征。随后采用两样本t检验和最小绝对收缩和选择算子(LASSO)回归筛选影像组学特征并建立Rad-score。采用单因素和多因素Cox比例风险回归模型探讨基线临床特征的预后价值并建立临床模型。构建基于Rad-score和临床特征的影像组学列线图以预测总生存期(OS)。在两个队列中评估三种模型的预测效能。

分别从T2加权(T2-w)和对比增强T1加权(CET1-w)图像中提取了1,345个特征,并选择了1,037个组内相关系数(ICC)>0.7的特征。最终,选择了20个特征构建Rad-score,其与OS显著相关。Rad-score在训练队列和验证队列中的C指数分别为0.733(95%置信区间(CI):0.645至0.816)和0.824(95% CI:0.766-0.882)。通过单因素和多因素分析,确定了三个OS的独立危险因素:Rad-score(HR:10.962,95% CI:3.417-35.167,P <0.001)、乳酸脱氢酶(LDH)水平(HR:3.009,95% CI:1.128-8.510,P = 0.028)和远处淋巴结受累(HR:2.966,95% CI:1.015-8.664,P = 0.047)。将治疗前远处淋巴结受累和LDH水平纳入临床模型,该模型在训练队列中的C指数为0.707(95% CI:0.600–0.814),在验证队列中为0.635(95% CI:0.527–0.743)。我们整合了Rad-score和临床变量,建立了放射组学列线图,其在两个队列中表现出令人满意的预测性能,C指数分别为0.849(95% CI:0.781-0.917)和0.931(95% CI:0.882-0.980)。放射组学列线图在预测鼻型ENKTL患者的OS方面比其他两个模型更准确。基于放射组学列线图,将两个队列中的患者分为低风险组和高风险组(P均< 0.05)。该列线图定义的高风险组表现出更短的OS。

展开英文摘要原文

We aim to explore the value of MRI-based radiomics signature in the prognosis of patients with nasal ENKTL.

A total of 159 nasal ENKTL patients were enrolled and divided into a training cohort (n=81) and a validation cohort (n=78) randomly. Radiomics features from pretreatment MRI examination were extracted, respectively. Then two-sample t-test and Least Absolute Shrinkage and Selection Operator (LASSO) regression were used to select the radiomics signatures and establish the Rad-score. Univariate and multivariate Cox proportional hazards regression models were used to investigate the prognostic value of baseline clinical features and establish clinical models. A radiomics nomogram based on the Rad-score and clinical features was constructed to predict Overall Survival (OS). The predictive efficacy of the three models was evaluated in two cohorts.

A total of 1,345 features were extracted from T2-weighted (T2-w) and Contrast-enhanced T1-weighted (CET1-w) images, respectively, and 1,037 features with Intraclass Correlation Coefficient (ICC) >0.7 were selected. Ultimately, 20 features were chosen to construct the Rad-score, which showed a significant association with OS. The C-indexes of the Rad-score were 0.733 (95% confidence interval (CI): 0.645 to 0.816) and 0.824 (95% CI: 0.766-0.882), respectively, in training and validation cohorts. Through the univariate and multivariate analyses, three independent risk factors for OS were identified: Rad-score (HR: 10.962, 95% CI: 3.417-35.167, P <0.001), lactate dehydrogenase (LDH) level (HR: 3.009, 95% CI: 1.128-8.510, P = 0.028) and distant lymph-node involvement (HR: 2.966, 95% CI: 1.015-8.664, P = 0.047). Patients with distal lymph node involvement and LDH level before treatment were included in the clinical model, which achieved a C-index of 0.707 (95% CI: 0.600–0.814) in the training cohort and 0.635 (95% CI: 0.527–0.743) in the validation cohort. We integrated the Rad-score and clinical variables to establish a radiomics nomogram, which exhibited a satisfactory prediction performance with the C-indexes of 0.849(95% CI: 0.781-0.917) and 0.931 (95% CI: 0.882-0.980) in two cohorts, respectively. The radiomics nomogram was more accurate in predicting OS in patients with nasal ENKTL than the other two models. Based on the radiomics nomogram, patients were categorized into low-risk and high-risk groups in two cohorts (P all < 0.05). The high-risk group defined by this nomogram exhibited a shorter OS.

The Rad-score was significantly correlated with OS for nasal ENKTL patients. Moreover, the MRI-based radiomics nomogram could be used for risk stratification and might guide individual treatment decisions.

论文信息

作者
Chen L、Wang Z、Fang X、Yu M、Ye H、Han L、Tian Y、Guo C
单位
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou 510060, Guangdong, China.China
期刊
Current medical imaging2025
原文标识
PubMed 40551696 · DOI 10.2174/0115734056319914250605053257